Figure 9.
Effects of Methyl-GBB (10 and 20 mg·kg−1) on the AAR (A) infarct size (B) and rat 24 h survival (C). Methyl-GBB was administered daily for 14 days. Data shown are the means ± SEM of at least eight animals. *P < 0.05, significantly different from control group; Tukey's test.